UCB contributes £3.6 million into R&D partnership with Oxford University
This article was originally published in Scrip
Executive Summary
UCB and Oxford University have entered into a three-year R&D collaboration aimed at developing new medicines to treat diseases in the fields of immunology and neurology. UCB is contributing £3.6 million towards the partnership, which aims to allow scientists from industry and academia to work together on pharmaceutical research projects.